4-112441466-C-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_025144.4(ALPK1):​c.*256C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.665 in 540,514 control chromosomes in the GnomAD database, including 120,186 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 35184 hom., cov: 32)
Exomes 𝑓: 0.66 ( 85002 hom. )

Consequence

ALPK1
NM_025144.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.0540

Publications

10 publications found
Variant links:
Genes affected
ALPK1 (HGNC:20917): (alpha kinase 1) This gene encodes an alpha kinase. Mice which were homozygous for disrupted copies of this gene exhibited coordination defects (PMID: 21208416). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
ALPK1 Gene-Disease associations (from GenCC):
  • retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BP6
Variant 4-112441466-C-G is Benign according to our data. Variant chr4-112441466-C-G is described in ClinVar as Benign. ClinVar VariationId is 1236964.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALPK1NM_025144.4 linkc.*256C>G 3_prime_UTR_variant Exon 16 of 16 ENST00000650871.1 NP_079420.3
ALPK1NM_001102406.2 linkc.*256C>G 3_prime_UTR_variant Exon 16 of 16 NP_001095876.1
ALPK1NM_001253884.2 linkc.*256C>G 3_prime_UTR_variant Exon 15 of 15 NP_001240813.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALPK1ENST00000650871.1 linkc.*256C>G 3_prime_UTR_variant Exon 16 of 16 NM_025144.4 ENSP00000498374.1

Frequencies

GnomAD3 genomes
AF:
0.679
AC:
103152
AN:
151990
Hom.:
35162
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.735
Gnomad AMI
AF:
0.752
Gnomad AMR
AF:
0.618
Gnomad ASJ
AF:
0.702
Gnomad EAS
AF:
0.723
Gnomad SAS
AF:
0.578
Gnomad FIN
AF:
0.691
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.658
Gnomad OTH
AF:
0.677
GnomAD4 exome
AF:
0.660
AC:
256177
AN:
388406
Hom.:
85002
Cov.:
2
AF XY:
0.655
AC XY:
133371
AN XY:
203566
show subpopulations
African (AFR)
AF:
0.734
AC:
8327
AN:
11344
American (AMR)
AF:
0.598
AC:
9086
AN:
15200
Ashkenazi Jewish (ASJ)
AF:
0.713
AC:
8751
AN:
12278
East Asian (EAS)
AF:
0.736
AC:
20790
AN:
28258
South Asian (SAS)
AF:
0.581
AC:
20877
AN:
35944
European-Finnish (FIN)
AF:
0.681
AC:
17580
AN:
25830
Middle Eastern (MID)
AF:
0.633
AC:
1091
AN:
1724
European-Non Finnish (NFE)
AF:
0.658
AC:
154537
AN:
234906
Other (OTH)
AF:
0.660
AC:
15138
AN:
22922
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
4046
8091
12137
16182
20228
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.679
AC:
103227
AN:
152108
Hom.:
35184
Cov.:
32
AF XY:
0.678
AC XY:
50388
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.735
AC:
30507
AN:
41486
American (AMR)
AF:
0.618
AC:
9440
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.702
AC:
2434
AN:
3468
East Asian (EAS)
AF:
0.723
AC:
3731
AN:
5160
South Asian (SAS)
AF:
0.576
AC:
2779
AN:
4824
European-Finnish (FIN)
AF:
0.691
AC:
7310
AN:
10574
Middle Eastern (MID)
AF:
0.626
AC:
184
AN:
294
European-Non Finnish (NFE)
AF:
0.658
AC:
44725
AN:
67996
Other (OTH)
AF:
0.676
AC:
1431
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1723
3446
5170
6893
8616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.675
Hom.:
4084
Bravo
AF:
0.677
Asia WGS
AF:
0.587
AC:
2045
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23569188) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
1.3
DANN
Benign
0.68
PhyloP100
-0.054
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs231253; hg19: chr4-113362622; API